89 related articles for article (PubMed ID: 33052342)
1. GNS561 exhibits potent
Halfon P; Bestion E; Zandi K; Andreani J; Baudoin JP; La Scola B; Mege JL; Mezouar S; Schinazi RF
bioRxiv; 2020 Oct; ():. PubMed ID: 33052342
[TBL] [Abstract][Full Text] [Related]
2. GNS561 Exhibits Potent Antiviral Activity against SARS-CoV-2 through Autophagy Inhibition.
Bestion E; Zandi K; Belouzard S; Andreani J; Lepidi H; Novello M; Rouquairol C; Baudoin JP; Rachid M; La Scola B; Mege JL; Dubuisson J; Schinazi RF; Mezouar S; Halfon P
Viruses; 2022 Jan; 14(1):. PubMed ID: 35062337
[TBL] [Abstract][Full Text] [Related]
3. Autophagy as an emerging target for COVID-19: lessons from an old friend, chloroquine.
Bonam SR; Muller S; Bayry J; Klionsky DJ
Autophagy; 2020 Dec; 16(12):2260-2266. PubMed ID: 32522067
[TBL] [Abstract][Full Text] [Related]
4. GNS561, a clinical-stage PPT1 inhibitor, is efficient against hepatocellular carcinoma
Brun S; Bestion E; Raymond E; Bassissi F; Jilkova ZM; Mezouar S; Rachid M; Novello M; Tracz J; Hamaï A; Lalmanach G; Vanderlynden L; Legouffe R; Stauber J; Schubert T; Plach MG; Courcambeck J; Drouot C; Jacquemot G; Serdjebi C; Roth G; Baudoin JP; Ansaldi C; Decaens T; Halfon P
Autophagy; 2022 Mar; 18(3):678-694. PubMed ID: 34740311
[TBL] [Abstract][Full Text] [Related]
5. The controversial therapeutic journey of chloroquine and hydroxychloroquine in the battle against SARS-CoV-2: A comprehensive review.
Das S; Ramachandran AK; Birangal SR; Akbar S; Ahmed B; Joseph A
Med Drug Discov; 2021 Jun; 10():100085. PubMed ID: 33846702
[TBL] [Abstract][Full Text] [Related]
6. Screening a Library of FDA-Approved and Bioactive Compounds for Antiviral Activity against SARS-CoV-2.
Biering SB; Van Dis E; Wehri E; Yamashiro LH; Nguyenla X; Dugast-Darzacq C; Graham TGW; Stroumza JR; Golovkine GR; Roberts AW; Fines DM; Spradlin JN; Ward CC; Bajaj T; Dovala D; Schulze-Gamen U; Bajaj R; Fox DM; Ott M; Murthy N; Nomura DK; Schaletzky J; Stanley SA
ACS Infect Dis; 2021 Aug; 7(8):2337-2351. PubMed ID: 34129317
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic Potential of Exploiting Autophagy Cascade Against Coronavirus Infection.
Maity S; Saha A
Front Microbiol; 2021; 12():675419. PubMed ID: 34054782
[TBL] [Abstract][Full Text] [Related]
8. In silico study of azithromycin, chloroquine and hydroxychloroquine and their potential mechanisms of action against SARS-CoV-2 infection.
Braz HLB; Silveira JAM; Marinho AD; de Moraes MEA; Moraes Filho MO; Monteiro HSA; Jorge RJB
Int J Antimicrob Agents; 2020 Sep; 56(3):106119. PubMed ID: 32738306
[TBL] [Abstract][Full Text] [Related]
9. GNS561, a new lysosomotropic small molecule, for the treatment of intrahepatic cholangiocarcinoma.
Brun S; Bassissi F; Serdjebi C; Novello M; Tracz J; Autelitano F; Guillemot M; Fabre P; Courcambeck J; Ansaldi C; Raymond E; Halfon P
Invest New Drugs; 2019 Dec; 37(6):1135-1145. PubMed ID: 30778887
[TBL] [Abstract][Full Text] [Related]
10. Novel quinoline substituted autophagy inhibitors attenuate Zika virus replication in ocular cells.
Singh S; Ahmad F; Aruri H; Das S; Parajuli P; Gavande NS; Singh PK; Kumar A
Virus Res; 2024 Jun; 347():199419. PubMed ID: 38880335
[TBL] [Abstract][Full Text] [Related]
11. Anti-SARS-CoV-2 Activity of Extracellular Vesicle Inhibitors: Screening, Validation, and Combination with Remdesivir.
Kongsomros S; Suksatu A; Kanjanasirirat P; Manopwisedjaroen S; Prasongtanakij S; Jearawuttanakul K; Borwornpinyo S; Hongeng S; Thitithanyanont A; Chutipongtanate S
Biomedicines; 2021 Sep; 9(9):. PubMed ID: 34572416
[TBL] [Abstract][Full Text] [Related]
12. Chloroquine and Hydroxychloroquine for the Prevention and Treatment of COVID-19: A Fiction, Hope or Hype? An Updated Review.
Saghir SAM; AlGabri NA; Alagawany MM; Attia YA; Alyileili SR; Elnesr SS; Shafi ME; Al-Shargi OYA; Al-Balagi N; Alwajeeh AS; Alsalahi OSA; Patra AK; Khafaga AF; Negida A; Noreldin A; Al-Amarat W; Almaiman AA; El-Tarabily KA; Abd El-Hack ME
Ther Clin Risk Manag; 2021; 17():371-387. PubMed ID: 33953559
[TBL] [Abstract][Full Text] [Related]
13. Autophagy in severe acute respiratory syndrome coronavirus 2 infection.
Chen D; Zhang H
Curr Opin Physiol; 2022 Oct; 29():100596. PubMed ID: 36187896
[TBL] [Abstract][Full Text] [Related]
14. Development of a Fluorescence-Based, High-Throughput SARS-CoV-2 3CL
Froggatt HM; Heaton BE; Heaton NS
J Virol; 2020 Oct; 94(22):. PubMed ID: 32843534
[TBL] [Abstract][Full Text] [Related]
15. In Vitro Evaluation of the Antiviral Activity of Methylene Blue Alone or in Combination against SARS-CoV-2.
Gendrot M; Jardot P; Delandre O; Boxberger M; Andreani J; Duflot I; Le Bideau M; Mosnier J; Fonta I; Hutter S; La Scola B; Pradines B
J Clin Med; 2021 Jul; 10(14):. PubMed ID: 34300178
[TBL] [Abstract][Full Text] [Related]
16. Water-soluble tocopherol derivatives inhibit SARS-CoV-2 RNA-dependent RNA polymerase.
Pacl HT; Tipper JL; Sevalkar RR; Crouse A; Crowder C; ; Ahmad S; Ahmad A; Holder GD; Kuhlman CJ; Chinta KC; Nadeem S; Green TJ; Petit CM; Steyn AJC; Might M; Harrod KS
bioRxiv; 2021 Jul; ():. PubMed ID: 34282419
[TBL] [Abstract][Full Text] [Related]
17. Antitumor effects of chloroquine/hydroxychloroquine mediated by inhibition of the NF-κB signaling pathway through abrogation of autophagic p47 degradation in adult T-cell leukemia/lymphoma cells.
Fauzi YR; Nakahata S; Chilmi S; Ichikawa T; Nueangphuet P; Yamaguchi R; Nakamura T; Shimoda K; Morishita K
PLoS One; 2021; 16(8):e0256320. PubMed ID: 34407152
[TBL] [Abstract][Full Text] [Related]
18. Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency.
Gordon CJ; Tchesnokov EP; Woolner E; Perry JK; Feng JY; Porter DP; Götte M
J Biol Chem; 2020 May; 295(20):6785-6797. PubMed ID: 32284326
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of hydroxychloroquine for post-exposure prophylaxis to prevent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among adults exposed to coronavirus disease (COVID-19): a structured summary of a study protocol for a randomised controlled trial.
Barnabas RV; Brown E; Bershteyn A; Miller RS; Wener M; Celum C; Wald A; Chu H; Wesche D; Baeten JM;
Trials; 2020 Jun; 21(1):475. PubMed ID: 32493478
[TBL] [Abstract][Full Text] [Related]
20. GNS561 acts as a potent anti-fibrotic and pro-fibrolytic agent in liver fibrosis through TGF-β1 inhibition.
Bestion E; Jilkova ZM; Mège JL; Novello M; Kurma K; Pour STA; Lalmanach G; Vanderlynden L; Fizanne L; Bassissi F; Rachid M; Tracz J; Boursier J; Courcambeck J; Serdjebi C; Ansaldi C; Decaens T; Halfon P; Brun S
Ther Adv Chronic Dis; 2020; 11():2040622320942042. PubMed ID: 32728410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
